Jayne E. Murray

Oncologist

Female📍 Sydney

About of Jayne E. Murray

Jayne E. Murray is an Oncologist based in Sydney, NSW, Australia. She looks after people who are dealing with cancer in the brain and nervous system, and also cancers that can start in other places but affect the body’s wiring and growth.


Her clinical work includes conditions such as embryonal tumours with multilayered rosettes, neuroblastoma, gliomatosis cerebri, brain tumours, ependymoma, glioma, and rhabdomyosarcoma. These can be tough diagnoses, and treatment often needs a careful, team-based plan. In many cases, the goal is to control the cancer, reduce symptoms, and support day-to-day wellbeing during treatment.


People may come in after scan results or biopsy findings, or after they’ve been referred because symptoms weren’t settling. At times, her role is to help explain what the options are, what the next steps could look like, and how treatment may affect things like energy levels, movement, and appetite. It’s not just about the medication or the procedure. It’s also about keeping the whole picture in mind.


While the exact years of experience and training details aren’t listed here, her focus is clearly on oncology care for these specific cancer types. That means being used to the real-world side of treatment too: managing side effects, adjusting plans when things change, and helping families and patients understand what to expect as therapy goes on.


She also keeps an eye on how care fits with the rest of the healthcare system. If other specialists are involved, she works alongside them so the plan is consistent and the handovers are smooth. Cancer care can move quickly, and it helps when the people involved are on the same page.


Research and clinical trial information can be important in oncology, especially for less common cancers. When relevant, clinical trial options and newer treatment approaches can be discussed as part of the overall decision-making process, guided by what’s suitable for the person’s situation.


For many patients, the first appointment can feel overwhelming. Jayne E. Murray’s approach is practical and grounded, focusing on clear next steps and steady support through the treatment journey.

Services & Conditions Treated

Embryonal Tumor with Multilayered RosettesNeuroblastomaGliomatosis CerebriBrain TumorEpendymomaGliomaRhabdomyosarcoma

Publications

1 total

Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma.

Nature communications • February 19, 2024

Frequently Asked Questions

What does Dr Jayne E. Murray specialise in?
Dr Jayne E. Murray is an oncologist based in Sydney, working with brain and soft tissue cancers. Her listed services include tumors like embryonal tumors with multilayered rosettes, neuroblastoma, gliomatosis cerebri, brain tumors, ependymoma, glioma and rhabdomyosarcoma.
Which conditions does she treat?
She treats conditions related to brain and nerve system cancers, including various brain tumors (such as gliomas and ependymomas) and cancers like rhabdomyosarcoma and neuroblastoma, among others.
How can I make an appointment with Dr Murray in Sydney?
To book an appointment, contact the clinic in Sydney where Dr Murray practices. They can provide available times and any requirements for new or returning patients.
What kinds of services are offered?
Her services focus on oncological care for pediatric and adult patients with brain and related tumors, including diagnosis, treatment planning and ongoing care for tumors such as embryonal tumors, neuroblastoma, gliomas and rhabdomyosarcoma.
What should I bring to the first visit?
For your first visit, bring any medical records, imaging results, current medications and a list of questions you want to discuss with the doctor. If you’re unsure what to bring, call the clinic before your appointment.
Is information about treatment options discussed with patients?
Yes. In general, discussions cover available treatment options, goals of care and what to expect during treatment. The exact plan will depend on the specific cancer type, stage and patient needs.